Luminal Toxin-Binding Agents for Clostridium difficile Infection
Conclusion:
LTBA monotherapy is inferior to vancomycin and metronidazole for CDI. Some data indicate possible benefit in reducing recurrent CDI, but outcomes with adjunctive and/or sequential LTBAs are unavailable. Further studies are needed to investigate the role of LTBAs for CDI.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: McCoy, R. M., Klick, A., Hill, S., Dull, R. B. Tags: Research Articles Source Type: research